SECURITIES AND EXCHANGE COMMISSION
                                    Washington, DC


             LITIGATION RELEASE NO. 16065 / February 18, 1999

             Securities  and  Exchange Commission v. Grady A. Sanders and
             Erica J. Hull, Civil Action No. 98-2346-LFO (D.D.C.)

                  On  February  2,  1999,  the  Securities  and  Exchange
             Commission ("Commission")  obtained  a  federal  court order
             requiring  Grady A. Sanders of Los Angeles to pay $1,115,195
             in  penalties   and   disgorgement   arising  from  Sander’s
             fraudulent  promotion  of  a  microcap company.  The  order,
             entered by the Honorable Louis  F.  Oberdorfer of the United
             States District Court for the District of Columbia, enforces
             payment of penalties and disgorgement  previously imposed by
             the  Commission  in  an  administrative proceeding.  Sanders
             consented to the entry of  the  District Court’s order.  The
             Commission filed its complaint, pursuant to Section 21(e) of
             the  Securities Exchange Act of 1934  ("Exchange  Act")  [15
             U.S.C.  §  78u(e)],  on  September  30,  1998. The complaint
             charged that Sanders failed to comply with  the terms of the
             prior Commission order imposing remedial sanctions issued in
             In  the  Matter  of New Allied Development Corp.,  Erica  J.
             Hull, and Grady A.  Sanders,  Administrative Proceeding File
             No. 3-8395 (November 26, 1996).

                  The  prior  Commission order  contained  findings  that
             Sanders and another respondent were responsible for material
             omissions  and  fraudulent   representations   concerning  a
             microcap  company’s,  New  Allied  Development  Corp.  ("New
             Allied"),  disclosure statements, made pursuant to  Exchange
             Act Rule 15c2-11,  and  press  releases  and  concluded that
             Sanders  and  the  other  respondent  violated the antifraud
             provisions of the Securities Act of 1933  ("Securities Act")
             and  the  Exchange  Act,  and of Rule 10b-5 thereunder.  The
             Commission  imposed  remedial   sanctions   on  Sanders  and
             required  him  to pay disgorgement of $115,195,  prejudgment
             interest on the  disgorgement  amount,  and  a  civil  money
             penalty  of  $1,000,000.  After  Sanders  failed  to pay the
             disgorgement  and penalty as ordered by the Commission,  the
             Commission initiated this action.

             For further information on this case, please see Exchange Act
             Releases 37990 and 34274.


                                NEWS DIGEST SUMMARY

                          SECURITIES AND EXCHANGE COMMISSION
                                   Washington, D.C.

             Litigation Release No. 16068 / February 24, 1999

             Accounting and Auditing Enforcement
             Release No.  1112 / February 24, 1999

             Securities and Exchange Commission v. Robert S. Barton, No.
             99-01881 (RCx) (C.D. Calif.) (February 23, 1999)

             SEC Sues Former Chief Financial Officer of Operating
             Division of Sunrise Medical Inc. for Accounting Fraud
             and Insider Trading

                  The Securities and Exchange Commission announced today
             the filing of an enforcement action in federal court in Los
             Angeles charging Robert S. Barton ("Barton"), the former
             chief financial officer of Bio Clinic Corporation ("Bio
             Clinic"), a division of Sunrise Medical Inc. ("Sunrise
             Medical"), with orchestrating a large-scale accounting fraud
             that inflated Sunrise Medical’s earnings by 16% in 1994 and
             40% in 1995.  The Commission also charged Barton with
             insider trading for exercising Sunrise Medical stock options
             when he knew that the company’s financial statements
             materially overstated its earnings.  Sunrise Medical is a
             Carlsbad, California manufacturer and distributor of medical
             devices.

                  The complaint alleges as follows:  Sunrise Medical set
             annual earnings bonus targets for its operating divisions,
             including Bio Clinic.  Annual awards under the bonus program
             were made to division management when the division met or
             exceeded its targets.  By 1994, Bio Clinic’s earnings were
             flagging and the division began having problems meeting its
             earnings targets.  In 1994 and 1995, Barton fraudulently
             reduced Bio Clinic's reported expenses by at least $19.6
             million by recording fictitious assets and improperly
             decreasing liabilities.  This enabled Bio Clinic to meet its
             earnings targets despite the financial problems it had begun
             experiencing.  Barton was awarded a bonus of over $25,000 in
             1994.  He did not receive a bonus in 1995 because the fraud
             had been detected.

                  To carry out his scheme, Barton solicited the help of
             Bio Clinic’s controller, Sharon Longview ("Longview"), and
             its accounting manager, Christie Rockwood ("Rockwood"), to
             make the improper accounting entries.  He also prevailed on
             the manager of Bio Clinic’s information systems, Vicki